Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort

Marco R. Di Tullio, Zhezhen Jin, Cesare Russo, Mitchell S V Elkind, Tatjana Rundek, Mitsuhiro Yoshita, Charles Decarli, Clinton B Wright, Shunichi Homma, Ralph L Sacco

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Objectives The purpose of this study was to evaluate the relationship between patent foramen ovale (PFO), ischemic stroke, and subclinical cerebrovascular disease in the general population. Background PFO is found more frequently in stroke patients than in stroke-free controls. However, the PFO-related stroke risk in the general population is not well established, and the relationship between PFO and silent brain infarcts (SBI) is not known. Methods PFO presence was assessed by transthoracic echocardiography with saline contrast injection in 1,100 stroke-free individuals over age 39 of a community-based sample followed for a mean of 11 years. In addition, 360 participants underwent brain magnetic resonance imaging (MRI) for SBI detection. We evaluated the risk of stroke associated with PFO after adjusting for established stroke risk factors and examined the odds of having SBI among those with and without PFO. Results PFO was present in 164 participants (14.9%). Over a mean follow-up of 11.0 ± 4.5 years, 111 ischemic strokes occurred (10.1%), 15 (9.2%) in the PFO+ and 96 (10.3%) in the PFO- groups. The 12.5-year cumulative risk of stroke was 10.1% (standard error: 2.5%) in the PFO+ and 10.4% (standard error: 1.1%) in the PFO- group (p = 0.46). The adjusted hazard ratio for PFO and stroke was 1.10 (95% confidence interval [CI]: 0.64 to 1.91). In the MRI subcohort, PFO was not associated with SBI (adjusted odds ratio: 1.15, 95% CI: 0.50 to 2.62). Conclusions In this community-based cohort, PFO was not associated with an increased risk of clinical stroke or subclinical cerebrovascular disease.

Original languageEnglish
Pages (from-to)35-41
Number of pages7
JournalJournal of the American College of Cardiology
Volume62
Issue number1
DOIs
StatePublished - Jul 2 2013

Fingerprint

Cerebrovascular Disorders
Patent Foramen Ovale
Stroke
Population
Brain
Magnetic Resonance Imaging
Confidence Intervals

Keywords

  • atrium
  • cerebrovascular disorders
  • echocardiography
  • epidemiology
  • stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort. / Di Tullio, Marco R.; Jin, Zhezhen; Russo, Cesare; Elkind, Mitchell S V; Rundek, Tatjana; Yoshita, Mitsuhiro; Decarli, Charles; Wright, Clinton B; Homma, Shunichi; Sacco, Ralph L.

In: Journal of the American College of Cardiology, Vol. 62, No. 1, 02.07.2013, p. 35-41.

Research output: Contribution to journalArticle

Di Tullio, Marco R. ; Jin, Zhezhen ; Russo, Cesare ; Elkind, Mitchell S V ; Rundek, Tatjana ; Yoshita, Mitsuhiro ; Decarli, Charles ; Wright, Clinton B ; Homma, Shunichi ; Sacco, Ralph L. / Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort. In: Journal of the American College of Cardiology. 2013 ; Vol. 62, No. 1. pp. 35-41.
@article{d4c129ac282e4d8885d9387a5ea212ae,
title = "Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort",
abstract = "Objectives The purpose of this study was to evaluate the relationship between patent foramen ovale (PFO), ischemic stroke, and subclinical cerebrovascular disease in the general population. Background PFO is found more frequently in stroke patients than in stroke-free controls. However, the PFO-related stroke risk in the general population is not well established, and the relationship between PFO and silent brain infarcts (SBI) is not known. Methods PFO presence was assessed by transthoracic echocardiography with saline contrast injection in 1,100 stroke-free individuals over age 39 of a community-based sample followed for a mean of 11 years. In addition, 360 participants underwent brain magnetic resonance imaging (MRI) for SBI detection. We evaluated the risk of stroke associated with PFO after adjusting for established stroke risk factors and examined the odds of having SBI among those with and without PFO. Results PFO was present in 164 participants (14.9{\%}). Over a mean follow-up of 11.0 ± 4.5 years, 111 ischemic strokes occurred (10.1{\%}), 15 (9.2{\%}) in the PFO+ and 96 (10.3{\%}) in the PFO- groups. The 12.5-year cumulative risk of stroke was 10.1{\%} (standard error: 2.5{\%}) in the PFO+ and 10.4{\%} (standard error: 1.1{\%}) in the PFO- group (p = 0.46). The adjusted hazard ratio for PFO and stroke was 1.10 (95{\%} confidence interval [CI]: 0.64 to 1.91). In the MRI subcohort, PFO was not associated with SBI (adjusted odds ratio: 1.15, 95{\%} CI: 0.50 to 2.62). Conclusions In this community-based cohort, PFO was not associated with an increased risk of clinical stroke or subclinical cerebrovascular disease.",
keywords = "atrium, cerebrovascular disorders, echocardiography, epidemiology, stroke",
author = "{Di Tullio}, {Marco R.} and Zhezhen Jin and Cesare Russo and Elkind, {Mitchell S V} and Tatjana Rundek and Mitsuhiro Yoshita and Charles Decarli and Wright, {Clinton B} and Shunichi Homma and Sacco, {Ralph L}",
year = "2013",
month = "7",
day = "2",
doi = "10.1016/j.jacc.2013.03.064",
language = "English",
volume = "62",
pages = "35--41",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort

AU - Di Tullio, Marco R.

AU - Jin, Zhezhen

AU - Russo, Cesare

AU - Elkind, Mitchell S V

AU - Rundek, Tatjana

AU - Yoshita, Mitsuhiro

AU - Decarli, Charles

AU - Wright, Clinton B

AU - Homma, Shunichi

AU - Sacco, Ralph L

PY - 2013/7/2

Y1 - 2013/7/2

N2 - Objectives The purpose of this study was to evaluate the relationship between patent foramen ovale (PFO), ischemic stroke, and subclinical cerebrovascular disease in the general population. Background PFO is found more frequently in stroke patients than in stroke-free controls. However, the PFO-related stroke risk in the general population is not well established, and the relationship between PFO and silent brain infarcts (SBI) is not known. Methods PFO presence was assessed by transthoracic echocardiography with saline contrast injection in 1,100 stroke-free individuals over age 39 of a community-based sample followed for a mean of 11 years. In addition, 360 participants underwent brain magnetic resonance imaging (MRI) for SBI detection. We evaluated the risk of stroke associated with PFO after adjusting for established stroke risk factors and examined the odds of having SBI among those with and without PFO. Results PFO was present in 164 participants (14.9%). Over a mean follow-up of 11.0 ± 4.5 years, 111 ischemic strokes occurred (10.1%), 15 (9.2%) in the PFO+ and 96 (10.3%) in the PFO- groups. The 12.5-year cumulative risk of stroke was 10.1% (standard error: 2.5%) in the PFO+ and 10.4% (standard error: 1.1%) in the PFO- group (p = 0.46). The adjusted hazard ratio for PFO and stroke was 1.10 (95% confidence interval [CI]: 0.64 to 1.91). In the MRI subcohort, PFO was not associated with SBI (adjusted odds ratio: 1.15, 95% CI: 0.50 to 2.62). Conclusions In this community-based cohort, PFO was not associated with an increased risk of clinical stroke or subclinical cerebrovascular disease.

AB - Objectives The purpose of this study was to evaluate the relationship between patent foramen ovale (PFO), ischemic stroke, and subclinical cerebrovascular disease in the general population. Background PFO is found more frequently in stroke patients than in stroke-free controls. However, the PFO-related stroke risk in the general population is not well established, and the relationship between PFO and silent brain infarcts (SBI) is not known. Methods PFO presence was assessed by transthoracic echocardiography with saline contrast injection in 1,100 stroke-free individuals over age 39 of a community-based sample followed for a mean of 11 years. In addition, 360 participants underwent brain magnetic resonance imaging (MRI) for SBI detection. We evaluated the risk of stroke associated with PFO after adjusting for established stroke risk factors and examined the odds of having SBI among those with and without PFO. Results PFO was present in 164 participants (14.9%). Over a mean follow-up of 11.0 ± 4.5 years, 111 ischemic strokes occurred (10.1%), 15 (9.2%) in the PFO+ and 96 (10.3%) in the PFO- groups. The 12.5-year cumulative risk of stroke was 10.1% (standard error: 2.5%) in the PFO+ and 10.4% (standard error: 1.1%) in the PFO- group (p = 0.46). The adjusted hazard ratio for PFO and stroke was 1.10 (95% confidence interval [CI]: 0.64 to 1.91). In the MRI subcohort, PFO was not associated with SBI (adjusted odds ratio: 1.15, 95% CI: 0.50 to 2.62). Conclusions In this community-based cohort, PFO was not associated with an increased risk of clinical stroke or subclinical cerebrovascular disease.

KW - atrium

KW - cerebrovascular disorders

KW - echocardiography

KW - epidemiology

KW - stroke

UR - http://www.scopus.com/inward/record.url?scp=84879353263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879353263&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2013.03.064

DO - 10.1016/j.jacc.2013.03.064

M3 - Article

VL - 62

SP - 35

EP - 41

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 1

ER -